Total planned funding: $646,698,532
Clear active filters
Zambia
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Zambia | $646,698,532 |
Organizational Types
| Private Contractor | $646,698,532 |
Program Areas
| Treatment | $477,638,859 |
| Care | $54,511,498 |
| Governance and Systems | $47,294,295 |
| Testing | $34,364,787 |
| Prevention | $32,889,093 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $309,921,573 |
| HTXS: Treatment: Adult Treatment | $150,224,264 |
| HVCT: Testing: HIV Testing and Counseling | $34,364,787 |
| HBHC: Care: Adult Care and Support | $31,620,223 |
| HLAB: Laboratory Infrastructure | $23,184,378 |
| OHSS: Health Systems Strengthening | $22,379,917 |
| PDTX: Treatment: Pediatric Treatment | $17,493,022 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,907,969 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $9,361,005 |
| HKID: Care: Orphans and Vulnerable Children | $9,262,252 |
| PDCS: Care: Pediatric Care and Support | $8,189,175 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $7,121,620 |
| HVTB: Care: TB/HIV | $5,439,848 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,050,000 |
| HMIN: Biomedical Prevention: Injection Safety | $1,948,499 |
| HVSI: Strategic Information | $1,730,000 |
| HMBL: Biomedical Prevention: Blood Safety | $500,000 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Chemonics International:
$424,024,958
Countries/Regions
John Snow, Inc:
$70,121,914
Countries/Regions
Abt Associates:
$12,090,186
Countries/Regions